Colle Capital Partners — 2023 Investments

1 investments dated 2023 · listed companies and verified rows first · show all

Sensydiasensydia.com in 𝕏May 2023

Sensydia develops non-invasive wireless cardiac monitoring technology using machine learning to diagnose and manage heart disease.

AI & Machine LearningHardwareHealthtechMedical DevicesLos Angeles, US

Anthony Arnold(CEO)inDr. Aman Mahajan(CMO)inRusty Page(President & COO)inKanav Saraf(Executive Officer)Erick Hawkins(Director)Victroia K. Grace(Director)

Board seatVictoria Grace· per SEC Form D

Co-investorsFrontier Venture Capital Orlando Health Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.